insights_auto
Pse është ulur M1RN34 7,72%?
Zhytu më thellëchevron_right
M1RN34:BVMF
Moderna Inc Bdr
46,65 BRL
arrow_downward
-7,72%(-3,90) 1D
6 tet, 5:06:00 m.d., GMT-3 · BRL
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për M1RN34...
Hap
50,54 BRL
I lartë
52,60 BRL
I ulët
46,64 BRL
Kapitalizimi i tregut
69,98 mld
Vëllimi mesatar
115,33 mijë
Vëllimi
0,00
Maksimumi 52-javor
54,38 BRL
Minimumi 52-javor
6,02 BRL
Aksionet në qarkullim
399,24 mln
Numri i punonjësve
5 mijë
Hap
50,54 BRL
I lartë
52,60 BRL
I ulët
46,64 BRL
Kapitalizimi i tregut
69,98 mld
Vëllimi mesatar
115,33 mijë
Vëllimi
0,00
Maksimumi 52-javor
54,38 BRL
Minimumi 52-javor
6,02 BRL
Aksionet në qarkullim
399,24 mln
Numri i punonjësve
5 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Investor's Business Daily
·
4 orë më parë
Biotechs Sell Off — These Are The Biggest Losers
Investing.com
·
6 orë më parë
Why is Moderna stock sliding today?
TipRanks
·
6 orë më parë
Why Is Moderna Stock (MRNA) Falling Today, October 6?
Kalkine Media
·
7 orë më parë
What Does Joining the Nasdaq Mean for Moderna (NASDAQ:MRNA) Shares?
Profili
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Rreth Moderna Inc Bdr
Drejtori ekzekutivStephane Bancel
Punonjësit4,7 mijë
Themeluar mësht 2010
Selia-
Sektori-
Uebsajtimodernatx.com